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Abstract 
Purpose: To determine the anti-osteoporotic effect of calycosin (CA) and investigate the mechanism 
involved. 
Methods: To establish a cell model of osteoporosis, MC3T3-E1 cells were treated with dexamethasone 
(DEX). Subsequently, the levels of accumulated reactive oxygen species (ROS) and subsequent 
apoptotic cell death (using flow cytometry) were determined. Relevant mRNA and protein expression 
levels were measured by quantitative reverse transcription polymerase chain reaction (qRT-PCR) and 
immunoblot respectively.  
Results: CA reduced the apoptosis and accumulation of ROS in DEX-treated cells. DEX induced the 
expression of caspase-3/-8/-9 in the cleavage of poly ADP ribose polymerase (PARP), whereas CA 
treatment decreased expression levels of caspase-3/-8/-9 and PARP. In addition, DEX treatment 
significantly suppressed the expression of nuclear factor-erythroid 2-related factor 2 (Nrf2) as well as its 
downstream targets, viz, heme oxygenase-1 and quinone oxidoreductase-1. Interestingly, CA treatment 
reversed this suppressive effect. It was also found that Nrf2 small interfering RNA effectively inhibited 
the protective effects of CA against DEX induced ROS overproduction as well as apoptosis.  
Conclusion: CA attenuates the cytotoxicity of DEX via inhibition of the generation of ROS and 
promotion of Nrf2 expression. These findings offer novel insights into a molecular approach to the 
treatment of glucocorticoid-induced osteoporosis via the application of natural compounds. 
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Osteoporosis is a threat to health, particularly in 
postmenopausal women [1]. Osteoporosis is 
characterized by imbalance in the processes of 
bone formation and resorption, resulting in 
degenerative bone mineral density and 
deteriorative bone microarchitecture, which 
eventually lead to loss of bone strength and an 
increased risk of fracture [2]. Normal process of 
bone metabolism largely rely on the dynamic 
equilibrium between bone formation and bone 
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resorption. Osteoclasts and osteoblasts have 
been reported to play a vital role in maintaining 
normal bone mass in bony remodeling [3]. The 
destruction of osteoblasts causes reduced bone 
formation and imbalanced bone metabolism. 
Glucocorticoids (GCs) are known to induce 
osteoporosis, primarily by suppressing 
osteoblast-mediated osteogenesis [4,5]. In this 
research, a cell model of osteoporosis was 
established by treating osteoblasts with a 
synthetic GC dexamethasone (DEX). 
 
Calycosin (CA) is a compound isolated from 
Radix astragali (Figure 1), referred as Huangqi in 
Chinese, which is widely used in traditional 
medicine in China. In traditional Chinese 
medicine, Qi is involved in vital substances that 
contribute to the physiological functions of 
organs and meridians. Specifically, Huangqi has 
been widely used to tonify Qi [6-8] and is 
reported to have a protective effect in 
postmenopausal women who suffer from 
osteoporosis [9]. Additionally, total flavones of 
astragalus extract have also been shown to 
increase the BMD of ovariectomized rats [10]. 
However, the effect of CA, which is one of the 
flavones in Radix astragali, on osteoporosis 
remains unclear. Therefore, the aim of the 
present study was to investigate the therapeutic 











MC3T3-E1 osteoblastic cell line (Shanghai Cell 
Bank, Chinese Academy of Sciences) was 
cultured in α-Modified Eagle's Medium (MEM) 
(Gibco, USA), supplemented with 10% fetal 
bovine serum (Thermo Fisher Scientific, USA) at 
37 oC in a 5 % CO2 humidified atmosphere.  
 
Assessment of cell viability 
 
To study the potential effects of CA on MC3T3-
E1 cells, different concentrations of CA (20 and 
80 μM) were used to pre-treat the cells (1x105 
cells/cm2) for 2 hrs at 37 ˚C. Subsequently, DEX 
(10 μM, Sigma-Aldrich, USA) was mixed with the 
culture medium and incubated for 24 hrs. A Cell 
Counting Kit (CCK)-8 kit (beyotime, China) was 
utilized to measure the cell viability described by 
Huang et al [11]. Then, 4 x 103 cells were 
dispersed in each well of a 96-well plate and 
cultured for 6, 12, 24 and 48 hrs respectively. 
Each well was dispersed with CCK-8 reagent 1 h 
prior to the incubation. Then, a microplate reader 
(BD Biosciences, USA) was utilized to measure 
the optical density at 450 nm wavelength. All the 
parallel experiments were repeated for >3 times. 
 
Measurement of apoptosis frequency 
 
The apoptosis rate of cells were evaluated using 
an Annexin V-FITC apoptosis detection kit 
(KeyGEN Biotech, China). MC3T3-E1 cells were 
harvested after treatment of DEX for 24 hrs, the 
mixture was washed with ice-cold 1xPBS buffer 
and re-suspended in 500μL binding buffer. After 
addition of 5 μL Annexin V stock solution, the 
mixture was incubated at 4 oC for 10 min. 
FACSCalibur flow cytometer (BD Biosciences, 
USA) was utilized to analyze immediately 
following the addition of 5 μL propidium iodide. 
 
Determination of ROS 
 
Flow cytometric analysis was applied to detect 
ROS levels in cells as described previously [12]. 
After incubating with dihydrorhodamine 123 (0.5 
μM; Sigma-Aldrich, USA) at 37 oC for 0.5 hrs, the 
MC3T3-E1 cells were washed with 1xPBS and 
re-suspended in complete medium. After this 
treatment, the fluorescent intensity was assessed 




TRIzol reagent (Gibco; Thermo Fisher Scientific) 
was utilized to separate Total RNA from the cells. 
RT-qPCR analysis was completed on an ABI 
7500 thermal cycler (Applied Biosystems), and 
20 ng template RNA was used in a 25 µL 
reaction volume with 2x SYBR® Green PCR 
Master mix (Thermo Fisher Scientific, USA) and 
gene specific primer pairs. cDNA was 
synthesized at 55 oC for 30 min following 
manufacture’s protocol. qRT-PCR cycles were 
stated in Table 1. 2-ΔΔCt value was adopted to 
quantify relative mRNA expression levels of the 
target genes, compared to GAPDH [13]. 
 





Pre-denaturation 94 2 min 1 
Denaturation 94 15 s 40 
Annealing 60 30 s 
Extension 68 50 s 
Extension  68 5 min 1 
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Table 2: Primers for RT-qPCR analysis 
 




































Cells were washed twice with 1xPBS buffer, then 
lysed in RIPA buffer (Beyotime, China) 
containing 1 % protease inhibitor cocktail (PIC) 
(Sigma-Aldrich, USA). The supernatant of the 
cell lysates was collected, and the protein 
concentrations were measured via BCA assay 
(Thermo Fisher Scientific, USA). Proteins (20-30 
μg) were separated by 10 - 12 % SDS-
polyacrylamide gels, which were transferred onto 
polyvinylidene fluoride membranes (Millipore, 
USA). After blocking, membranes were 
incubated with primary antibodies including anti-
caspases -3, -8, and -9 (1:1000; catalog nos. 
ab2171, ab25901 and ab52298; Abcam, UK), 
anti- PARP (1:1000; catalog no. ab4830; Abcam, 
UK), anti-Nrf2 (1:1000; catalog no. PA5-19830; 
Invitrogen, USA), anti-HO1 (1:1000; catalog no. 
MA1-112; Invitrogen, USA), anti-NQO1 (1:1000; 
catalog no. 39-3700; Invitrogen, USA), and anti-
GAPDH (1:1500; catalog no. MA5-15738; 
Invitrogen, USA) for 1 h at room temperature. 
After wash with 1xPBS buffer, membranes were 
subsequently incubated with goat anti-mouse 
(catalog no. A23610) or goat anti-rabbit (catalog 
no. A23620) secondary HRP antibody (1:1000; 
Beyotime, China) for 45 min at 22 ˚C. Bands 
were developed using enhanced 
chemiluminescence (ECL) (Thermo Fisher 
Scientific, USA) and quantified by densitometry 
analysis of Quantity One® 1-D Analysis software 
(V. 4.6.8; Bio-Rad, USA).  
 
RNA interference  
 
To achieve a confluence of 60 - 80 % 
confluence, 2 × 105 MC3T3-E1 cells per well 
were seeded and cultured overnight. The 
silencing assay was performed according to 
manufacturer's protocol, with a Nrf2 small 
interfering (si) RNA assay kit that contained a 
pool of three 19-25 nucleotide target-specific 
Nrf2 siRNAs (catalog no. sc-37049; Santa Cruz 
Biotechnology, USA). Expression levels of Nrf2 
and its downstream targets, i.e., HO1 and NQO1, 




SPSS (version 16.0, IBM, USA) was applied to 
analyze the experimental results. One-way 
analysis of variance (ANOVA) was performed. 
Type of post-hoc test is dependent on whether 
the variances are homogeneous (LSD) or 
heterogeneous (Dunnett T3). Statistical 





Effect of CA on cell viability 
 
To investigate the effects of CA on cell 
proliferation, a CCK-8 assay was performed 
(Figure 2). We observed that >20 μM doses of 
CA significantly increased the viability of the 
MC3T3-E1 cells at 6, 12, 24, and 48 hrs (Figure 
2A). In addition, CA promoted cell proliferation in 
a dose- and time-dependent way. Hence, 20 and 
80 μM doses of CA were used in the following 
studies. 
 
Effect of CA on the DEX-induced apoptosis 
 
To investigate effects of CA on apoptosis, DEX-
treated cells were treated with CA. The results 
demonstrated that cells viability was significantly 
suppressed by DEX compared to the untreated 
group. However, CA significantly increased the 
viability of the DEX-treated cells in a dose- and 
time-dependent way (Figure 2 B). Moreover, 
apoptotic rates of the cells in the control, DEX, 
CA 20 µM and CA 80 µM groups were also 
measured (Figure 3 A). Treatment with DEX lead 
to an apoptotic frequency of 36.42 %, compared 
to 6.84 % in the control group. However, CA 
decreased the apoptotic frequency to 28.26 (20 
μM) and 14.35 % (80 μM). Therefore, CA  
Fu et al 




Figure 2: Effect of CA on MC3T3-E1 cell viability. (A) Cells were exposed to CA (concentrations at 0, 5, 10, 20, 
50, 80, and 100 μM) for 6, 12, 24 and 48 h, then CCK8 assay was used to ascertain the cell viability. (B) Different 
doses of CA (0, 20 and 80 μM) were used to treat the cells for 2 h. Treated cells were then exposed to DEX for 
24 h. Cell viability was quantified by a CCK8 assay. (Error bar: mean ± SD; n = 6; ##p < 0.01, vs. the untreated 




Figure 3: Effects of CA on ROS and apoptotic levels in DEX- treated cells. (A) Cells were treated with series of 
doses of CA (0, 20 and 80 μM) for 2 h, followed by 24 h DEX exposure. Apoptosis was measured using Annexin 
V assay. (B) ROS levels, determined by flow cytometry. (Error Bar: mean ± SD; n = 6; ##p < 0.01, vs. the 
untreated group; **p < 0.01, vs. the DEX-treated group). Abbreviation: CA, calycosin; DEX, dexamethasone 
 
exhibited a protective effect against apoptosis 
upon DEX treatment. 
 
Effect of CA on ROS production following 
DEX treatment 
 
As shown in Figure 3 C, ROS levels were 
significantly increased following 24 h of DEX 
treatment, as compared to control group levels. 
However, treatment with 20 and 80 µM CA 
effectively reduced the higher ROS level 
observed in the DEX-treated group. 
 
Effect of CA on caspase-3/-8/-9 and PARP 
expression levels 
 
The immunoblot analysis showed the levels of 
caspase-3/-8/-9 increased dramatically in DEX 
treated MC3T3-E1 cells (Figure 4 A-B), 
suggesting DEX-induced apoptosis was 
mediated by mitochondria and/or death receptor. 
However, CA treatment (20 and 80 μM) 
significantly suppressed the DEX-induced 
activation and upregulation of caspases (-3, -8 
and -9) in a dose-dependent way of the inhibition 
occurred simultaneously. In addition, DEX 
treatment resulted in PARP cleavage (Figure 4).  
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Figure 4: Effect of CA on caspase-3/-8/-9 and PARP expression levels. Cells were treated with different doses of 
CA (0, 20 and 80 μM) for 2 h, followed by 12 h of DEX exposure. (A) Caspase-3/-8/-9 and PARP expression 
levels were quantified using immunoblot. (B) Quantification of the Western blot results. (Error Bar: mean ± SD; n 
= 6; ##p < 0.01, vs. the untreated group; **p < 0.01, vs. the DEX-treated group). Abbreviation: CA, calycosin; DEX, 




Figure 5: Effect of CA on Nrf2 and its downstream targets. Levels of mRNA expression of (A) Nrf2, (B) NQO1 
and (C) HO1. (D) Protein expression levels of Nrf2, NQO1 and HO1. (E) Quantification of protein expression. 
(Error Bar: mean ± SD; n = 6; ##p < 0.01, vs. the untreated group; **p < 0.01, vs. the DEX-treated group). 
Abbreviation: CA, calycosin; DEX, dexamethasone 
 
As expected, this cleavage was suppressed by 
the addition of CA (20 and 80 μM). Taken 
together, the results demonstrated that CA 
inhibited apoptosis in osteoblastic cells. 
 
Effect of CA on Nrf2 signaling 
 
The RT-qPCR and western blot showed DEX 
treatment suppressed mRNA levels of Nrf2 and 
its downstream effectors (Figure 5 A-C). 
However, CA reversed this decrease. As shown 
in Figure 5 D and E, the expression levels of 
Nrf2, HO1 and NQO1 were significantly 
suppressed in DEX-treated MC3T3-E1 cells. 
After CA treatment, Nrf2, HO1, and NQO1 
expression was effectively recovered, suggesting 
that CA inhibited the DEX-induced ROS 
production via Nrf2 signaling activation. 
 
Involvement of Nrf2 pathway in the 
interactions of DEX and CA  
 
As the results shown in Figure 6A, Nrf2-siRNA 
downregulated levels of Nrf2, HO1 and NQO1, 
demonstrating Nrf2 silencing was effective. The 
effects on apoptosis of DEX-induced cell arising 
from Nrf2-knockdown were also examined. As 
shown in Figure 6 A-B, CA reduced DEX-induced  
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Figure 6: Effect of CA on Nrf2 signaling. (A) Protein levels of Nrf2, HO1 and NQO1 after treatment with siRNA-
Nrf2 for 24 h. Effect of CA on apoptosis (B) and ROS levels (C). (Error Bar: mean ± SD; n = 6; ##p < 0.01, vs. the 
untreated group; **p < 0.01, vs. the DEX-treated group). Abbreviation: CA, calycosin; DEX, dexamethasone  
 
apoptosis that resulted from ROS 
overproduction. In addition, Nrf2-siRNA inhibited 
the protective effects of CA. Thus, Nrf2 
knockdown recovered the DEX-induced 
cytotoxicity. Supplementation of CA reversed the 
DEX-induced cell apoptosis from 31 to 11.6 %. 
However, Nrf2 siRNA increased the apoptotic 
rate of MC3T3-E1 cells to 23.7 %. CA reduced 
the DEX-induced ROS overproduction from 212 
% in the control to 119 %, showing a recovery of 




CA, a phytoestrogen, is a major active flavonoid 
in Radix Astragali [14,15], which shows 
antitumor, antioxidative and anti-osteoporotic 
abilities [6]. It is reported that calycosin-7-O-β-D-
glucopyranoside inhibits osteoclast development 
in vitro and bone loss in vivo. Through regulating 
the bone morphogenetic protein/WNT signaling 
pathways, calycosin-7-O-β-D-glucopyranoside 
can also promote the osteoblastic cell 
differentiation in ST2 model (16). CA also exerts 
a protective role in bone loss in ovariectomized 
rats in a dose-dependent way [17]. Here, we 
explored the effects of CA on MC3T3-E1 cells 
upon DEX treatment, a synthetic GC. Our 
research revealed that CA promoted cell 
proliferation in a dose-/time-dependent way. In 
the DEX -treated cells, CA decreased the 
apoptosis rate and intracellular levels of ROS. 
Collectively, CA exhibited protective effects on 
the DEX-treated MC3T3-E1 cells. 
 
Generation of ROS can cause loss of 
mitochondrial membrane potential, which 
ultimately resulting in cell apoptosis. Our data 
illustrated that the supplementation of CA 
effectively inhibited the rapid onset and time-
dependent production of ROS, which is induced 
by DEX. Our findings demonstrated that CA 
protected MC3T3-E1 cells from cytotoxicity via 
inhibiting ROS production. The study also 
demonstrated downstream effects caused by 
increased ROS production in osteoblastic cells. 
Functioning as one of the major regulators of 
cytoprotective responses, the Nrf2 signaling 
pathway responds to changes in ROS and 
electrophiles that are associated with 
endogenous and exogenous stress [18,19]. 
Therefore, western blot and qRT-PCR analyses 
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are useful methods for determining the effects of 
DEX treatment on Nrf2 and its downstream 
genes. These results illustrated that mRNA levels 
of Nrf2, HO1 and NQO1 were decreased in the 
DEX-treated MC3T3-E cells. To examine the role 
of Nrf2 signaling in DEX-induced apoptotic cell 
death, we analyzed the ability of DEX to induce 
and the ability of CA to protect against apoptosis 
using Nrf2-siRNA. The results showed that CA 
protected against DEX-induced apoptosis and 
increased ROS levels. These protective effects 





The findings of this study demonstrate that ROS-
mediated downregulation of Nrf2 contributes to 
DEX-induced cytotoxicity in MC3T3-E1 
osteoblastic cells, and that CA reverses DEX-
cytotoxicity by inhibiting the accumulation of ROS 
and promoting the expression of Nrf2. These 
results provide an insight into potential molecular 
treatment strategies for DEX-induced osteo-
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